Brain natriuretic peptide increases urinary albumin and alpha-1 microglobulin excretion in Type 1 diabetes mellitus

Diabetic Medicine

Volumn 18, Issue 12, 2001, Pages 973-978

  McKenna, K ^a   Smith, D ^b   Moore, K ^b   Glen, A ^a   Tormey, W ^b   Thompson, C J ^a,b  

^a VICTORIA INFIRMARY   (United Kingdom)

^b BEAUMONT HOSPITAL   (Ireland)

Author keywords

Atrial natriuretic peptide; Brain natriuretic peptide; Diabetes mellitus; Microalbuminuria

Indexed keywords

ALBUMIN; ALPHA 1 MICROGLOBULIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CREATININE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DIURESIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PROTEIN STRUCTURE; RANDOMIZED CONTROLLED TRIAL; STEADY STATE; URINARY EXCRETION;

ADULT; ALBUMINURIA; ALPHA-GLOBULINS; ATRIAL NATRIURETIC FACTOR; CREATININE; DIABETES MELLITUS, TYPE 1; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; NATRIURETIC PEPTIDE, BRAIN; PLACEBOS;

EID: 0035673084     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0742-3071.2001.00569.x     Document Type: Article

References (45)

1. Early detection of patients at risk of developing diabetic nephropathy
2. Microalbuminuria as a predictor of clinical nephropathy in insulin dependent diabetes mellitus
3. Predicting diabetic nephropathy in insulin dependent diabetic patients
4. Elevated plasma atrial natriuretic peptide levels in diabetic rats
5. Atrial natriuretic factor in hypertensive and normotensive diabetic subjects
6. Increased plasma atrial natriuretic factor and reduced plasma renin in patients with poorly controlled diabetes mellitus
7. The role of human atrial natriuretic peptide in the pathogenesis of nephropathy in patients with Type 1 diabetes mellitus
8. Is atrial natriuretic peptide associated with hyperfiltration in diabetics?
9. Atrial natriuretic factor in various stages of diabetic nephropathy
10. Role of atrial natriuretic peptide in the pathogenesis of sodium retention in IDDM with and without glomerular hyperfiltration
11. Effect of glucose, insulin and hypertonicity on atrial natriuretic peptide levels in man
12. Effect of acute hyperinsulinaemia on plasma atrial and brain natriuretic peptide concentrations
13. Acute hyperglycaemia causes elevation of plasma atrial natriuretic peptide concentrations in Type 1 diabetes mellitus
14. Enhanced albuminuric response to atrial natriuretic peptide in normoalbuminuric patients with Type 1 diabetes mellitus; a pilot study
15. Effect of atrial natriuretic peptide on renal and vascular permeability in diabetes mellitus
16. Atrial natriuretic peptide increases urinary albumin excretion in men with Type 1 diabetes mellitus and established microalbuminuria
17. Angiotensin converting enzyme inhibition blocks the albuminuric effect of atrial natriuretic peptide in Type 1 diabetes
18. Expression of brain natriuretic peptide gene in human heart; production in the ventricle
19. Renal, endocrine and haemodynamic effects of human brain natriuretic peptide in normal man
20. Renal, endocrine and haemodynamic interactions of atrial and brain natriuretic peptides in normal man
21. The effects of pathophysiological increments in brain natriuretic peptide in left ventricular systolic dysfunction
22. Brain natriuretic peptide as a cardiac hormone in essential hypertension
23. Plasma levels of brain natriuretic peptide in healthy subjects and patients with essential hypertension; response to posture
24. Urinary immunoreactive brain natriuretic peptide in patients with renal disease
25. Clearance of brain natriuretic peptide in patients with chronic heart failure; indirect evidence for a neutral endopeptidase mechanism but against an atrial natriuretic peptide clearance receptor mechanism
26. Assay of brain natriuretic peptide (BNP) in human plasma; evidence for high molecular weight BNP as a major component in heart failure
27. Plasma brain natriuretic peptide concentrations in normotensive non insulin dependent diabetic patients with microalbuminuria
28. Plasma concentrations of atrial and brain natriuretic peptides in Type 1 diabetes
29. Prevention of glomerular hyperfiltration in rats with streptozotocin induced diabetes by an atrial natriuretic peptide receptor antagonist
30. Antagonist for atrial natriuretic peptide receptor ameliorates glomerular hyperfiltration in diabetic rats
31. Participation of endogenous atrial natriuretic peptide in the regulation of urinary protein excretion in experimental diabetic rats
32. Atrial natriuretic peptide causes preglomerular vasodilation and postglomerular vasoconstriction in rat kidney
33. Blood levels and renal effects of atrial natriuretic factor in normal man
34. Differential effects of atrial natriuretic peptide and dopamine on urinary protein excretion in chronic glomerulonephritis
35. Renal mechanisms of atrial natriuretic peptide in man
36. Effects of physiological increments in human atrial natriuretic peptide and brain natriuretic peptide in normal male subjects
37. Renal clearance and isolated kidney techniques
38. Effect of atriopeptin 11 on haematocrit and volaemia of nephrectomised rats
39. Contribution of ANP to plasma protein escape during VE; effects of thiorphan and atrial appendectomy
40. Atrial natriuretic peptide increases albuminuria in Type 1 diabetic patients: Evidence for blockade of tubular protein reabsorption
41. Enhanced urinary excretion of albumin and B2 microglobulin in essential hypertension induced by atrial natriuretic peptide
42. The effect of atrial natriuretic factor on urinary albumin and B2 microglobulin in man
43. Tubular dysfunction and microalbuminuria in insulin dependent diabetes
44. Receptors of atrial natriuretic factor
45. Natriuretic peptide responses to acute and chronic ventricular pacing in sheep